RxDoctor Payments Data

Christopher Fatti

Podiatrist · Syracuse, NYNPI 1386887537

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $7,349 of the $8,526 with a category attached, or 86.2%. 21 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 25.4% of the total. 2025 is the largest year on record at $3,581, 3.6 times the $1,000 reported in 2019. Among podiatrist clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,526in general payments, 2019–2025

Across 186 payments — averaging $45.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$2K
  • Prodigy Surgical Distribution, Inc.$1K
  • Organogenesis Inc.$883
  • Stryker$746
  • Johnson & Johnson$692
  • Arthrex$545
  • plus $2K from 15 others

What the payments were for

  • Travel & lodging$1,17714%
  • Food & beverage$7,34986%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,526 in reported general payments places this provider in the 95th percentile of 862 podiatrist providers in New York.

See all podiatrist providers in New York

Medicare billing

Part B allowed, 2024
$211,361
Medicare patients
466
Services billed
13,363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium19$877
Ciprofloxacin Hcl24$301
Cephalexin20$299
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen43$297
Doxycycline Hyclate22$269
Ammonium Lactate11$229
Meloxicam69$184
Methylprednisolone23$174
Mupirocin22$159
Terbinafine Hcl21$155
Tramadol Hcl27$148
Naproxen13$122
Oxycodone Hcl28$108
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$88
Colchicine12$86

Paid to pharmacies, not to this prescriber.

Other podiatrist in Syracuse

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →